Free Trial
OTCMKTS:ARTH

Arch Therapeutics (ARTH) Stock Price, News & Analysis

Arch Therapeutics logo

About Arch Therapeutics Stock (OTCMKTS:ARTH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.00
$0.24
52-Week Range
N/A
Volume
1 shs
Average Volume
4,068 shs
Market Capitalization
$763 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arch Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARTH Stock News Headlines

Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
Arch Therapeutics, Inc. (ARTH)
See More Headlines

ARTH Stock Analysis - Frequently Asked Questions

Arch Therapeutics, Inc. (OTCMKTS:ARTH) issued its quarterly earnings results on Thursday, July, 23rd. The biotechnology company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01.

Shares of ARTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arch Therapeutics investors own include NVIDIA (NVDA), Broadcom (AVGO), CymaBay Therapeutics (CBAY), Arista Networks (ANET), Adobe (ADBE), GE Aerospace (GE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
7/23/2020
Today
8/28/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:ARTH
Previous Symbol
NASDAQ:ARTH
CIK
1537561
Fax
N/A
Employees
10
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.98 million
Net Margins
-8,257.70%
Pretax Margin
-8,257.70%
Return on Equity
N/A
Return on Assets
-730.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.10
Quick Ratio
0.01

Sales & Book Value

Annual Sales
$80 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.43) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
4,742,000
Free Float
4,529,000
Market Cap
$763 thousand
Optionable
Not Optionable
Beta
4.02

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (OTCMKTS:ARTH) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners